For many Americans, pharmaceutical drugs are too expensive—and thanks to a system of complex and tedious bureaucracy, any effort for meaningful reform has been futile. Cost Plus Drugs wants to change ...

Mark Cuban Cost Plus Drugs has expanded its partnership with GraphiteRx to support the Cost Plus Marketplace for Businesses. The platform combines Cost Plus Drugs’ pricing model with GraphiteRx’s ...

Mark Cuban Cost Plus Drug Company continues to disrupt the pharmaceutical market by partnering with health systems to supply hospitals with cheap medicine. It recently announced it would also import ...

Mark Cuban (center), co-founder of Cost Plus Drugs explains his company's discussions with Humana to develop "direct-to-employer" prescription drug programs that bypass traditional pharmacy benefit ...

Penn Medicine has enlisted Mark Cuban Cost Plus Drug Company to secure key generics for its retail pharmacy network. Penn will lean on the Cost Plus Marketplace for 100 of the most frequently ...

Mark Cuban is best known for basketball and billions, but lately, the long-time “Shark Tank” veteran, social media influencer and regular TV personality has been focused on healthcare. He created Cost ...

WILMINGTON, Del.--(BUSINESS WIRE)--Truveris, a leading healthcare technology company focused on reducing pharmacy spend, announced today that they are collaborating with Mark Cuban Cost Plus Drug ...

Giant Eagle is the latest pharmacy to join the Mark Cuban Cost Plus Drugs retailer network. Giant Eagle Pharmacy customers who participate in the Cost Plus Drugs program can now pick up qualifying ...

DALLAS — Hospital operator Community Health Systems Inc. has expanded its partnership with Mark Cuban Cost Plus Drugs Co. by increasing the kinds of medicines it will purchase from the company, ...

In a landscape where the cost of medications can be prohibitively high and the Federal Trade Commission (FTC) scrutinizing Pharmacy Benefit Managers (PBM) over pricing structures and high markups like ...

The rise of more transparent, “Cost Plus” pharmacy models is stirring debate within the pharmaceutical space as smaller players put pressure on the large PBMs. In January 2022, entrepreneur Mark Cuban ...